- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hyperlipoproteinemia Type II in United Kingdom
Total 28253 results
-
University of ExeterKing's College London; Benaroya Research Institute; Royal Devon and Exeter NHS...RecruitingType1 Diabetes MellitusNetherlands, United States, United Kingdom
-
Great Ormond Street Hospital for Children NHS Foundation...Recruiting
-
University of LeicesterUniversity Hospitals, Leicester; Loughborough University; Baker Heart and Diabetes...CompletedType 2 Diabetes MellitusUnited Kingdom
-
University Hospitals, LeicesterDepartment of Health, United KingdomUnknownType 2 Diabetes MellitusUnited Kingdom
-
State University of New York at BuffaloSunstar, Inc.CompletedPeriodontitis | Diabetes Mellitus, Type IIUnited States
-
University of California, San FranciscoCompletedOsteoporosisUnited States
-
Canterbury Christ Church UniversityCompletedAn Online, Compassion Intervention for Adults With Type 1 and Type 2 Diabetes Mellitus (T1DM; T2DM).Type 1 Diabetes | Type 2 DiabetesUnited Kingdom
-
Royal Devon and Exeter NHS Foundation TrustUniversity of ExeterActive, not recruitingType 1 Diabetes | Type 1 Diabetes Mellitus Maturity OnsetUnited Kingdom
-
PfizerCompletedHyperlipidemiaUnited States, Canada
-
Esperion Therapeutics, Inc.Completed
-
Stanford UniversityCompletedInflammation | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-OnsetUnited States
-
University of LeicesterUniversity Hospitals, LeicesterCompletedType 2 Diabetes MellitusUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II;Pompe's DiseaseCzechia, Taiwan, Belgium, Germany, Korea, Republic of, United States, Argentina, Australia, Austria, Brazil, Canada, Denmark, France, Hungary, Italy, Japan, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Switzerland, Turk... and more
-
University of CambridgeCambridge University Hospitals NHS Foundation Trust; Nottingham University... and other collaboratorsCompletedType 1 Diabetes MellitusUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, Taiwan, Israel, United Kingdom, France
-
Forest LaboratoriesPhenomixTerminatedDiabetes Mellitus, Type IIUnited States, Belarus, Colombia, Hungary, India, Lithuania, Peru, Romania
-
University College, LondonUniversity of IowaUnknownCharcot-Marie-Tooth Disease, Type IA | Charcot-Marie-Tooth Disease Type 2A | Charcot-Marie-Tooth Disease, Type IB | Charcot-Marie-Tooth Disease, Type XUnited Kingdom
-
Société des Produits Nestlé (SPN)CompletedType 2 DiabetesUnited Kingdom
-
Catabasis PharmaceuticalsCompletedDyslipidemia | Hypercholesterolemia | HypertriglyceridemiaUnited States, Canada
-
Liverpool Hope UniversityCompleted
-
University of RochesterCompletedObesity | Cardiovascular Disease | Health Behavior | Type II DiabetesUnited States
-
University of ManchesterNorthern Care Alliance NHS Foundation Trust; University of Oxford; Manchester...Recruiting
-
University of AberdeenCompletedType 2 DiabetesUnited Kingdom
-
AstraZenecaCompleted
-
University of NottinghamUnknown
-
NestléCompletedDiabetes Type 2United Kingdom
-
University of SurreyNovo Nordisk A/SCompleted
-
Intermountain Health Care, Inc.Merck Sharp & Dohme LLC; AbbottCompletedType II Diabetes Mellitus | Mixed DyslipidemiaUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited Kingdom
-
Solvay PharmaceuticalsCompletedType 2 Diabetes MellitusUnited Kingdom
-
Solvay PharmaceuticalsCompleted
-
Dana-Farber Cancer InstituteMedWaves, IncNot yet recruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
Liverpool John Moores UniversityLiverpool University Hospitals NHS Foundation TrustCompleted
-
PfizerCompleted
-
Intercept PharmaceuticalsCompletedFatty Liver | Diabetes Mellitus, Type IIUnited States
-
Susan ChangGE Healthcare; Sigma-Aldrich; Phillips-MedisizeRecruitingRecurrent WHO Grade III Glioma | WHO Grade III Glioma | WHO Grade II Glioma | Recurrent World Health Organization (WHO) Grade II GliomaUnited States
-
Queen's University, BelfastWithdrawn
-
Royal Devon and Exeter NHS Foundation TrustKing's College London; Newcastle University; NHS Tayside; University of Dundee; University... and other collaboratorsCompleted
-
University of DundeeNHS TaysideCompleted
-
Poxel SACompletedType 2 Diabetes MellitusUnited Kingdom
-
Duke UniversityGenzyme, a Sanofi CompanyCompletedNeuropathy | Myopathy | Glycogen Storage Disease Type II (Late-onset Pompe Disease)United States
-
University of LeicesterNovo Nordisk A/S; University Hospitals, LeicesterCompletedCardiovascular Disease | Type 2 Diabetes MellitusUnited Kingdom
-
State University of New York at BuffaloCompletedDental Malocclusion | Crowding, Tooth | Angle Class II | Angle Class IUnited States
-
Burzynski Research InstituteWithdrawnRecurrent Mantle Cell Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell LymphomaUnited States
-
Radiant ResearchCompletedHyperglycemia | Dyslipidemia | HyperlipidemiaUnited States
-
NHS LothianNHS Tayside; DexCom, Inc.RecruitingType 1 Diabetes MellitusUnited Kingdom
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States